New research: GLP-1 drugs may reduce asthma attacks

Date:

Share this article:

Del denne artikel:

Researchers are now investigating whether a type of medication used to treat obesity could also help reduce asthma-related problems.

GLP-1 medications are currently used primarily to treat diabetes and obesity, but researchers have discovered that the drugs may also benefit people with asthma.

At a conference hosted by the American Academy of Allergy, Asthma, and Immunology, and reported on by Verywell Health, data from more than 3,000 patients was presented.

The findings showed that people using GLP-1 medication experienced fewer asthma attacks than those who did not receive the treatment.

The study found a reduction of between 12 and 15 percent among patients who were overweight or obese.

Also read: How dark chocolate may affect your blood pressure if you eat it every day

Obesity affects asthma

According to researchers, obesity can worsen asthma symptoms. Excess weight may put pressure on the lungs, while fat tissue can increase inflammation in the body. This may lead to more breathing difficulties.

Experts also emphasize that weight loss often helps people with chronic illnesses, especially asthma.

However, researchers still do not know whether the improvements are caused by the medication itself, the weight loss, or a combination of both.

For that reason, further studies will now be conducted to better understand the effects.

Also read: Many take magnesium every day – experts warn of risks

Not yet approved

Asthma is not currently an approved treatment indication for GLP-1 medications.

This means patients may not necessarily receive insurance coverage or public healthcare support for the medication.

However, experts believe this could change if future studies show clear results.

For now, people with asthma and obesity are advised to speak with their doctor about possible treatment options.

Also read: Walking after surgery may improve patients’ recovery

Sources: Verywell Health and the American Academy of Allergy, Asthma, and Immunology.

Also read: Why you don’t need to throw away your expired spices

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Skin-to-skin contact is linked to a lower risk of death in premature babies, review finds

A large review of nearly 50 trials suggests the practice still isn't standard in many hospitals, and that may cost lives.

7 signs your body has been making too much cortisol – even when you think you’re coping

Many people live for years with raised cortisol without realizing it, and the warning signs look nothing like ordinary tiredness.

A common stroke drug may also slow joint damage

The drug has been used for years to prevent strokes, and animal tests now hint at a very different job for it.

Forget sleeping pills: This tiny patch could be the future of better sleep

The skin-worn device uses gentle sound waves to nudge the sleeping brain, and early tests hint at a calmer stress response too.

Skin-to-skin contact is linked to a lower risk of death in premature babies, review finds

A large review of nearly 50 trials suggests the practice still isn't standard in many hospitals, and that may cost lives.

7 signs your body has been making too much cortisol – even when you think you’re coping

Many people live for years with raised cortisol without realizing it, and the warning signs look nothing like ordinary tiredness.

A common stroke drug may also slow joint damage

The drug has been used for years to prevent strokes, and animal tests now hint at a very different job for it.